Valneva SE (VALN) Capital Expenditures (2021 - 2026)

Valneva SE (VALN) posted quarterly Capital Expenditures of -$281074.7 for Q1 2026, up 82.38% year-on-year from -$154112.9 in Q1 2025, and down 103.19% on a QoQ basis from $8.8 million in Q4 2025.

Valneva SE (VALN) Capital Expenditures (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Capital Expenditures for 6 consecutive years, with -$281074.7 the latest figure, recorded in Q1 2026.

  • Quarterly Capital Expenditures rose 82.38% year-over-year to -$281074.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 67.13% YoY) and the FY2025 annual result came in at $5.0 million, down 68.12% from the prior year.
  • Capital Expenditures eased to -$281074.7 in Q1 2026 per VALN's latest filing, from $8.8 million in the prior quarter.
  • Over the last five years, Capital Expenditures for VALN reached as high as $8.1 billion in Q3 2023 and fell as low as -$8.1 billion in Q2 2023.
  • A 5-year average of $4.1 million and a median of -$1.4 million in 2025 frame the typical range for Capital Expenditures.
  • The largest YoY upside for Capital Expenditures was 109815.52% in 2023 against a maximum downside of 108932.34% in 2023.
  • Year by year, Capital Expenditures stood at $58.9 million in 2022, then plunged by 56.33% to $25.7 million in 2023, then grew by 5.69% to $27.2 million in 2024, then sank by 67.51% to $8.8 million in 2025, then tumbled by 103.19% to -$281074.7 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$281074.7, $8.8 million, and -$760153.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -281,074.70

Historic Data

Download Data
DateValue
Mar 31, 2026 -281,074.70
Mar 31, 2026 -281,074.70
Dec 31, 2025 8.82 Mn
Dec 31, 2025 8.82 Mn
Sep 30, 2025 -760,153.45
Sep 30, 2025 -760,153.45
Jun 30, 2025 -1.44 Mn
Jun 30, 2025 -1.44 Mn
Mar 31, 2025 -1.60 Mn
Mar 31, 2025 -1.60 Mn
Dec 31, 2024 27.16 Mn
Dec 31, 2024 27.16 Mn
Sep 30, 2024 -6.72 Mn
Sep 30, 2024 -6.72 Mn
Jun 30, 2024 448,353.98
Jun 30, 2024 448,353.98
Mar 31, 2024 -5.12 Mn
Mar 31, 2024 -5.12 Mn
Dec 31, 2023 25.70 Mn
Dec 31, 2023 25.70 Mn